Fifth Third Bancorp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.21M | Buy |
11,209
+7,419
| +196% | +$1.43M | ﹤0.01% | 1168 |
|
|
2025
Q4 | $697K | Buy |
3,790
+552
| +17% | +$96.8K | ﹤0.01% | 686 |
|
|
2025
Q3 | $497K | Buy |
3,238
+460
| +17% | +$69.6K | ﹤0.01% | 821 |
|
|
2025
Q2 | $388K | Buy |
2,778
+143
| +5% | +$20K | ﹤0.01% | 826 |
|
|
2025
Q1 | $387K | Sell |
2,635
-134
| -5% | -$19.4K | ﹤0.01% | 810 |
|
|
2024
Q4 | $363K | Sell |
2,769
-5,582
| -67% | -$781K | ﹤0.01% | 829 |
|
|
2024
Q3 | $1.3M | Buy |
8,351
+337
| +4% | +$54.4K | ﹤0.01% | 556 |
|
|
2024
Q2 | $1.25M | Sell |
8,014
-344
| -4% | -$51.8K | ﹤0.01% | 552 |
|
|
2024
Q1 | $1.13M | Sell |
8,358
-722
| -8% | -$95.6K | ﹤0.01% | 577 |
|
|
2023
Q4 | $1.22M | Buy |
9,080
+1,390
| +18% | +$181K | 0.01% | 552 |
|
|
2023
Q3 | $1.04M | Sell |
7,690
-74
| -1% | -$10.1K | ﹤0.01% | 566 |
|
|
2023
Q2 | $1.11M | Buy |
7,764
+1,169
| +18% | +$172K | ﹤0.01% | 557 |
|
|
2023
Q1 | $916K | Buy |
6,595
+1,024
| +18% | +$138K | ﹤0.01% | 584 |
|
|
2022
Q4 | $755K | Sell |
5,571
-1,675
| -23% | -$210K | ﹤0.01% | 607 |
|
|
2022
Q3 | $795K | Buy |
7,246
+3,562
| +97% | +$452K | ﹤0.01% | 593 |
|
|
2022
Q2 | $487K | Buy |
3,684
+1,984
| +117% | +$260K | ﹤0.01% | 693 |
|
|
2022
Q1 | $226K | Sell |
1,700
-255
| -13% | -$30.6K | ﹤0.01% | 962 |
|
|
2021
Q4 | $228K | Sell |
1,955
-594
| -23% | -$69.9K | ﹤0.01% | 978 |
|
|
2021
Q3 | $306K | Buy |
2,549
+1,028
| +68% | +$120K | ﹤0.01% | 847 |
|
|
2021
Q2 | $182K | Sell |
1,521
-1,466
| -49% | -$161K | ﹤0.01% | 1008 |
|
|
2021
Q1 | $297K | Buy |
2,987
+565
| +23% | +$56.8K | ﹤0.01% | 822 |
|
|
2020
Q4 | $242K | Buy |
2,422
+24
| +1% | +$2.54K | ﹤0.01% | 865 |
|
|
2020
Q3 | $263K | Buy |
2,398
+702
| +41% | +$78.1K | ﹤0.01% | 783 |
|
|
2020
Q2 | $179K | Sell |
1,696
-242
| -12% | -$25K | ﹤0.01% | 908 |
|
|
2020
Q1 | $173K | Sell |
1,938
-626
| -24% | -$58.9K | ﹤0.01% | 880 |
|
|
2019
Q4 | $256K | Buy |
2,564
+130
| +5% | +$12.2K | ﹤0.01% | 862 |
|
|
2019
Q3 | $217K | Sell |
2,434
-418
| -15% | -$36.2K | ﹤0.01% | 890 |
|
|
2019
Q2 | $235K | Sell |
2,852
-66
| -2% | -$5.17K | ﹤0.01% | 866 |
|
|
2019
Q1 | $236K | Sell |
2,918
-6,416
| -69% | -$506K | ﹤0.01% | 836 |
|
|
2018
Q4 | $709K | Sell |
9,334
-2,466
| -21% | -$193K | 0.01% | 531 |
|
|
2018
Q3 | $934K | Sell |
11,800
-4,611
| -28% | -$349K | 0.01% | 518 |
|
|
2018
Q2 | $1.15M | Sell |
16,411
-4,637
| -22% | -$334K | 0.01% | 488 |
|
|
2018
Q1 | $1.47M | Sell |
21,048
-3,530
| -14% | -$245K | 0.01% | 438 |
|
|
2017
Q4 | $1.71M | Buy |
24,578
+64
| +0.3% | +$4.32K | 0.01% | 420 |
|
|
2017
Q3 | $1.66M | Sell |
24,514
-880
| -3% | -$55.6K | 0.01% | 430 |
|
|
2017
Q2 | $1.73M | Sell |
25,394
-858
| -3% | -$56K | 0.01% | 429 |
|
|
2017
Q1 | $1.64M | Buy |
26,252
+6,726
| +34% | +$392K | 0.01% | 436 |
|
|
2016
Q4 | $1.07M | Sell |
19,526
-1,556
| -7% | -$88.3K | 0.01% | 530 |
|
|
2016
Q3 | $1.39M | Buy |
21,082
+18,766
| +810% | +$1.23M | 0.01% | 472 |
|
|
2016
Q2 | $140K | Buy |
2,316
+52
| +2% | +$3.02K | ﹤0.01% | 1000 |
|
|
2016
Q1 | $128K | Buy |
2,264
+129
| +6% | +$7.75K | ﹤0.01% | 1032 |
|
|
2015
Q4 | $145K | Sell |
2,135
-138
| -6% | -$9.05K | ﹤0.01% | 1033 |
|
|
2015
Q3 | $145K | Sell |
2,273
-907
| -29% | -$59.7K | ﹤0.01% | 1044 |
|
|
2015
Q2 | $203K | Buy |
3,180
+735
| +30% | +$50.3K | ﹤0.01% | 991 |
|
|
2015
Q1 | $167K | Buy |
2,445
+458
| +23% | +$31.8K | ﹤0.01% | 1036 |
|
|
2014
Q4 | $140K | Buy |
1,987
+167
| +9% | +$12K | ﹤0.01% | 1056 |
|
|
2014
Q3 | $130K | Sell |
1,820
-84
| -4% | -$6.15K | ﹤0.01% | 1081 |
|
|
2014
Q2 | $141K | Sell |
1,904
-22,526
| -92% | -$1.63M | ﹤0.01% | 1061 |
|
|
2014
Q1 | $1.58M | Sell |
24,430
-5,359
| -18% | -$346K | 0.01% | 492 |
|
|
2013
Q4 | $1.77M | Sell |
29,789
-9,287
| -24% | -$505K | 0.02% | 458 |
|
|
2013
Q3 | $2.03M | Sell |
39,076
-444
| -1% | -$22.3K | 0.02% | 421 |
|
|
2013
Q2 | $1.87M | Buy |
+39,520
| New | +$2.01M | 0.02% | 442 |
|
Other funds holding AZN
IA
VCM
VAM
Fifth Third Bancorp's AZN Position: Q1 2026 in Review
Fifth Third Bancorp increased its AstraZeneca (AZN) stake by 196% in Q1 2026, buying an estimated $1.43M and bringing the position to 11,209 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1168.
Fifth Third Bancorp first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Fifth Third Bancorp held 11,209 shares of AstraZeneca worth $2.21M as of Q1 2026.
- Fifth Third Bancorp bought 7,419 AstraZeneca shares in Q1 2026, an estimated $1.43M.
- AstraZeneca made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1168 holding.
- Fifth Third Bancorp first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.